Regulus Therapeutics
RGLS
#8838
Rank
HK$0.86 B
Marketcap
HK$13.10
Share price
-6.39%
Change (1 day)
-35.89%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -HK$0.36 Billion

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.36 Billion56.97%
2023 -HK$0.23 Billion6.51%
2022 -HK$0.22 Billion2.53%
2021 -HK$0.21 Billion93.59%
2020 -HK$0.11 Billion-15.41%
2019 -HK$0.13 Billion-64.46%
2018 -HK$0.36 Billion-33.26%
2017 -HK$0.54 Billion-13.98%
2016 -HK$0.63 Billion44.77%
2015 -HK$0.44 Billion-1.63%
2014 -HK$0.45 Billion203.6%
2013 -HK$0.15 Billion8.65%
2012 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$34.16 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$61.74 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
HK$14.81 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$81.11 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$1.84 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.77 Billion 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$65.15 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.92 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA